Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components
2006
Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature
2008
Benefit-Risk Assessment of Leflunomide
2009
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
2012 Standout
The epidemiology of ankylosing spondylitis
1993
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Rheumatoid arthritis
2018 Standout
Psoriasis
2009 Standout
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
2003 Standout
Rheumatoid arthritis
2016 Standout
Autoimmune Diseases
2001
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
2003
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes
2012 StandoutNobel
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials
2009
Toward a Mechanism-Based Approach to Pain Diagnosis
2016
Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction
2011
Pharmacological treatment of established rheumatoid arthritis
2003
Emerging role of extracellular vesicles in inflammatory diseases
2014
Juvenile idiopathic arthritis
2007 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Effect of mechanical loading on mRNA levels of common endogenous controls in articular chondrocytes and intervertebral disk
2005
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
2005 Standout
The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
2008 Standout
Generation of human induced pluripotent stem cells from osteoarthritis patient-derived synovial cells
2011
Long‐term open‐label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular‐course juvenile rheumatoid arthritis
2005
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
2006
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve‐week randomized, double‐blind, placebo‐controlled trial followed by an open‐label extension up to week fifty‐two
2008
Superior efficacy of combination therapy for rheumatoid arthritis: Fact or fiction?
2005
Prospective, Pilot, Open-Label, Short-Term Study of Conversion to Leflunomide Reverses Chronic Renal Allograft Dysfunction
2002
Ankylosing spondylitis
2007 Standout
Caspase Functions in Cell Death and Disease
2013 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial
2002
Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis
2002 Standout
A systematic medline analysis of therapeutic approaches in ankylosing spondylitis
2009
The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review
2011 Standout
Efficacy and safety of leflunomide in active rheumatoid arthritis
2000
Safety evaluation of leflunomide in rheumatoid arthritis
2013
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Rheumatoid arthritis
2010 Standout
The juvenile-onset spondyloarthritides
2002
Similar effects of disease‐modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: Meta‐analysis of 70 randomized placebo‐controlled or drug‐controlled studies, including 112 comparisons
2010
Tofacitinib versus Methotrexate in Rheumatoid Arthritis
2014
Repair and tissue engineering techniques for articular cartilage
2014 Standout
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007 Standout
At the crossroads of gout and psoriatic arthritis: “psout”
2020
Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis
2004
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
VALVULAR DISEASE ASSOCIATED WITH SYSTEMIC ILLNESS
1998
Special Invited Papers Section: Therapeutic Equivalence – Clinical Issues and Statistical Methodology in Noninferiority Trials
2005
Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints
2011
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight-week, multicenter, randomized, double-blind, placebo-controlled study
2001
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review
2003
Are animal models useful for studying human disc disorders/degeneration?
2007 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Aortic root disease and valve disease associated with ankylosing spondylitis
1998
Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials
2004
The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria?
2005 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Methotrexate in Rheumatoid Arthritis
1987
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
2016 Standout
The Spectrum of Vasculitis
1978 Standout
Review of teriflunomide and its potential in the treatment of multiple sclerosis
2009
Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: A multinational, double‐blind, randomized, placebo‐controlled clinical trial
2004
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Wegener's Granulomatosis
1974
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
2003 Standout
Gout
2021 Standout
Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway.
1985
Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years
1983 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
2016 Standout
Endocarditis Due to Rare and Fastidious Bacteria
2001 Standout
Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis
2008
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Works of B Gömör being referenced
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
2000
Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial
2006
Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis
2001
Juvenile psoriatic arthritis
1991
Synovial fluid exoglycosidases are predictors of rheumatoid arthritis and are effective in cartilage glycosaminoglycan depletion
2003
Chondrogenic Potential of Mesenchymal Stem Cells from Patients with Rheumatoid Arthritis and Osteoarthritis: Measurements in a Microculture System
2008
Distribution of HLA B27 and ankylosing spondylitis in the Hungarian population.
1977
Cardiac and cardiopulmonary disorders in patients with ankylosing spondylitis and rheumatoid arthritis.
1988